FTC批准Ascension拟以39亿美元收购AmSurg案的最终同意令，要求剥离七家手术中心
FTC Approves Final Consent Order in Ascension Health-AmSurg Deal
美国联邦贸易委员会（FTC）就Ascension拟以39亿美元收购AmSurg LLC一案批准最终同意令。命令要求Ascension剥离位于田纳西州纳什维尔、佛罗里达州巴拿马城、俄克拉何马州塔尔萨、得克萨斯州韦科和堪萨斯州威奇托的七家门诊手术中心，其中六家转让给SC Affiliates，巴拿马城的一家转让给Florida Gastroenterology Center。
The Federal Trade Commission finalized a consent order involving Ascension Health Alliance’s (Ascension) proposed $3.9 billion acquisition of AmSurg LLC.
The FTC’s final consent order requires Ascension to divest seven AmSurg ambulatory surgery centers across Nashville, Tennessee; Panama City, Florida; Tulsa, Oklahoma; Waco, Texas and Wichita, Kansas. Six of the centers will be divested to SC Affiliates, while the seventh center in Panama City will be divested to Florida Gastroenterology Center.
The FTC’s final consent order settles allegations that Ascension’s acquisition of AmSurg would limit competition for certain outpatient surgical services performed by gastroenterologists, ophthalmologists and orthopedists across the Nashville, Panama City, Tulsa, Waco and Wichita metro areas. Limited competition for these surgical services likely would lead to higher surgery prices for patients, while also threatening to lower the quality of care and limit surgical services innovation, the FTC’s complaint alleged.
The final consent order also imposes other conditions, including requiring Ascension to provide the Commission with prior notice for any acquisition of ambulatory surgical centers in the metropolitan areas around the divested surgical centers.
Following a public comment period, the Commission voted 2-0 to approve the final order.
来源：美国联邦贸易委员会 · 竞争与反垄断 · ftc.gov